Advertisement
Screener

Jazz Pharmaceuticals plc (JAZZ) Graph

JAZZ Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $1.21B; Research and development (m); Selling, general and administrative $389.20M; Operating expenses (m).
  • 2026-03-31: Revenue $1.07B; Research and development (m); Selling, general and administrative $352.70M; Operating expenses (m).
  • 2025-12-31: Revenue $1.20B*; Research and development (m); Selling, general and administrative $406.21M*; Operating expenses (m).
  • 2025-09-30: Revenue $1.13B; Research and development (m); Selling, general and administrative $530.65M; Operating expenses (m).

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

JAZZ revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Defitelio Defibrotide$62.00MEpidiolex Epidyolex$292.10MEpilepsy$292.10MHigh Sodium AG OxybateProduct Royalty Revenue$42.20MModeyso$48.20MOncology$362.30MOther Products$0.00Other Royalty AndContract Revenues$10.00MProduct And Services ProductSales Net Of Deductions$1.16BProduct And ServicesRoyalties And Contract Revenue$52.20MRylaze Enrylaze$99.50MSleep$501.70MVyxeos$31.40MXyrem$30.50MXywav$471.20MZepzelca$105.80MZiihera$15.40MRevenue$1.21BOperating income$248.20MSelling, general& administrative$389.20MPre-tax income$211.00MIncome tax$18.10MNet income$192.80M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

JAZZ revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Europe$97.40MOther Countries$33.00MUS$1.08BRevenue$1.21BOperating income$248.20MSelling, general& administrative$389.20MPre-tax income$211.00MIncome tax$18.10MNet income$192.80M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$1.21B(m)$389.20M(m)$18.10M$192.80M
2026-03-31$1.07B(m)$352.70M(m)$6.10M$293.10M
2025-12-31$1.20B*(m)$406.21M*(m)$4.96M*(m)
2025-09-30$1.13B(m)$530.65M(m)-$242.42M$251.41M
2025-06-30$1.05B(m)$358.40M(m)-$17.20M-$718.50M
2025-03-31$897.80M(m)$514.00M(m)-$17.80M-$92.50M
2024-09-30$1.05B(m)$325.77M(m)-$14.53M$215.06M
2024-06-30$1.02B(m)$338.52M(m)-$30.65M$168.57M
2024-03-31$901.98M(m)$351.71M(m)$11.67M-$14.62M
2023-09-30$972.14M(m)$308.31M(m)-$47.18M$146.82M
2023-06-30$957.32M(m)$340.84M(m)-$24.32M$104.44M
2023-03-31$892.81M(m)$297.92M(m)-$15.32M$69.42M
2022-09-30$940.65M(m)$358.48M(m)-$43.03M-$19.65M
2022-06-30$932.88M(m)$366.47M(m)-$16.11M$34.66M
2022-03-31$813.72M(m)$308.81M(m)$536.00K$1.65M
2021-09-30$838.12M(m)$363.68M(m)-$18.06M-$52.83M
2021-06-30$751.81M(m)$429.03M(m)$228.62M-$363.32M
2021-03-31$607.58M(m)$260.51M(m)$18.02M$121.83M
2020-12-31$665.52M(m)(m)(m)(m)$133.41M
2020-09-30$600.89M(m)$207.25M(m)$19.28M$148.23M
2020-06-30$562.44M(m)$191.41M(m)$54.75M$114.80M
2020-03-31$534.73M(m)$208.40M(m)-$51.29M-$157.83M
2019-12-31$581.74M$97.38M*(m)(m)(m)$73.99M
2019-09-30$537.70M$79.86M$178.71M(m)$10.90M$102.28M
2019-06-30$534.13M$62.38M$176.01M(m)-$78.65M$261.90M
2019-03-31$508.19M$60.10M$167.95M(m)$29.12M$85.20M
2018-12-31$476.46M(m)(m)$291.40M*(m)$159.47M
2018-09-30$469.37M$51.16M$155.87M$280.60M$19.35M$149.32M
2018-06-30$500.48M$56.13M$158.58M$347.28M$36.52M$92.32M
2018-03-31$444.61M$62.67M$207.21M$356.81M$19.15M$45.99M
2017-12-31$436.40M(m)(m)(m)(m)$232.21M
2017-09-30$411.86M$47.36M$124.52M$325.40M$1.24M$63.53M
2017-06-30$394.39M$40.16M$132.33M$229.34M$35.52M$105.60M
2017-03-31$376.05M$44.93M$144.25M$239.91M$29.16M$86.51M
2016-12-31$396.62M(m)(m)(m)(m)$116.69M
2016-09-30$374.18M$47.80M$124.37M$237.93M$26.44M$89.83M
2016-06-30$381.16M$39.09M$122.62M$212.43M$42.11M$114.50M
2016-03-31$336.01M$31.25M$128.76M$214.85M$32.34M$75.81M
2015-12-31$340.88M(m)(m)(m)(m)$82.76M
2015-09-30$340.87M$50.78M$104.04M$209.34M$29.95M$87.96M
2015-06-30$333.75M$27.83M$107.13M$180.45M$30.65M$88.11M
2015-03-31$309.30M$27.18M$112.39M$192.54M$32.06M$70.70M
2014-12-31$328.14M(m)(m)(m)(m)$81.61M
2014-09-30$306.58M$22.42M$93.50M$248.55M$24.22M$25.77M
2014-06-30$291.23M$20.09M$100.56M$216.94M$19.35M$43.66M
2014-03-31$246.92M$18.11M$106.36M$313.58M$17.03M-$92.65M
2013-12-31$235.77M(m)(m)(m)(m)$55.29M
2013-09-30$232.16M$11.83M$74.97M$131.60M$18.34M$75.41M
2013-06-30$208.25M$9.25M$77.51M$131.19M$23.61M$42.19M
2013-03-31$196.24M$6.75M$70.53M$128.05M$17.63M$43.42M
2012-12-31$183.70M(m)(m)(m)(m)$200.55M
2012-09-30$175.51M$6.92M$60.92M$120.22M$12.86M$33.21M
2012-06-30$124.23M$2.32M$57.22M$84.80M$6.59M$27.14M
2012-03-31$102.53M$3.96M$44.36M$66.79M$5.52M$27.68M
2011-12-31$83.54M(m)(m)(m)(m)$37.47M
2011-09-30$73.29M$3.28M$30.55M$39.59M$0.00$32.48M
2011-06-30$64.57M$3.38M$22.09M$30.71M$0.00$33.20M
2011-03-31$50.88M$3.69M$19.91M$28.28M(m)$21.83M
2010-12-31$83.54M(m)(m)(m)(m)$37.47M
2010-09-30$73.29M$7.32M$18.04M$30.31M(m)$32.48M
2010-06-30$64.57M$7.96M$17.10M$29.90M(m)$33.20M
2010-03-31$50.88M(m)(m)(m)(m)$21.83M

Revenue and expense 6 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$2.28B(m)$741.90M(m)$24.20M$485.90M
2025-06-30$1.94B(m)$872.40M(m)-$35.00M-$811.00M
2024-06-30$1.93B(m)$690.24M(m)-$18.98M$153.95M
2023-06-30$1.85B(m)$638.76M(m)-$39.65M$173.86M
2022-06-30$1.75B(m)$675.29M(m)-$15.58M$36.31M
2021-06-30$1.36B(m)$689.54M(m)$246.64M-$241.48M
2020-06-30$1.10B(m)$399.81M(m)$3.47M-$43.03M
2019-06-30$1.04B$122.49M$343.96M(m)-$49.53M$347.10M
2018-06-30$945.09M$118.80M$365.79M$704.09M$55.67M$138.31M
2017-06-30$770.44M$85.08M$276.58M$469.26M$64.67M$192.12M
2016-06-30$717.17M$70.34M$251.38M$427.27M$74.45M$190.31M
2015-06-30$643.05M$55.01M$219.52M$372.99M$62.71M$158.81M
2014-06-30$538.15M$38.20M$206.92M$530.52M$36.38M-$48.99M
2013-06-30$404.49M$16.00M$148.03M$259.24M$41.24M$85.61M
2012-06-30$226.76M$6.28M$101.58M$151.59M$12.11M$54.83M
2011-06-30$115.45M$7.08M$42.01M$58.98M$0.00$55.03M
2010-06-30$75.66M$14.18M$33.89M$57.85M(m)-$4.92M

Revenue and expense 9 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$3.07B(m)$1.40B(m)-$277.41M-$559.60M
2024-09-30$2.98B(m)$1.02B(m)-$33.52M$369.00M
2023-09-30$2.82B(m)$947.07M(m)-$86.82M$320.68M
2022-09-30$2.69B(m)$1.03B(m)-$58.60M$16.66M
2021-09-30$2.20B(m)$1.05B(m)$228.58M-$294.32M
2020-09-30$1.70B(m)$607.06M(m)$22.75M$105.20M
2019-09-30$1.58B$202.34M$522.67M(m)-$38.63M$449.38M
2018-09-30$1.41B$169.96M$521.66M$984.68M$75.02M$287.63M
2017-09-30$1.18B$132.45M$401.11M$794.66M$65.91M$255.64M
2016-09-30$1.09B$118.14M$375.75M$665.20M$100.89M$280.14M
2015-09-30$983.92M$105.80M$323.56M$582.33M$92.65M$246.77M
2014-09-30$844.73M$60.62M$300.42M$779.07M$60.60M-$23.23M
2013-09-30$636.65M$27.82M$223.00M$390.84M$59.57M$161.02M
2012-09-30$402.28M$13.20M$162.50M$271.81M$24.97M$88.03M
2011-09-30$188.74M$10.36M$72.55M$98.57M$0.00$87.51M
2010-09-30$120.41M$21.49M$51.93M$88.16M(m)$8.32M

Revenue and expense 12 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$4.27B(m)$1.81B(m)-$272.44M-$356.15M
2024-12-31$4.07B(m)$1.39B(m)-$91.43M$560.12M
2023-12-31$3.83B(m)$1.34B(m)-$119.91M$414.83M
2022-12-31$3.66B(m)$1.42B(m)-$158.65M-$224.06M
2021-12-31$3.09B(m)$1.45B(m)$216.12M-$329.67M
2020-12-31$2.36B(m)$854.23M(m)$33.52M$238.62M
2019-12-31$2.16B$299.73M$736.94M(m)-$73.15M$523.37M
2018-12-31$1.89B$226.62M$683.53M$1.28B$80.16M$447.10M
2017-12-31$1.62B$198.44M$544.16M$1.09B-$47.74M$487.85M
2016-12-31$1.49B$162.30M$502.89M$896.32M$135.24M$396.83M
2015-12-31$1.32B$135.25M$449.12M$816.58M$106.40M$329.54M
2014-12-31$1.17B$85.18M$406.11M$977.29M$94.23M$58.39M
2013-12-31$872.42M$41.63M$304.30M$532.11M$91.64M$216.31M
2012-12-31$585.98M$20.48M$223.88M$388.13M-$83.79M$288.59M
2011-12-31$272.28M$14.12M$108.94M$144.45M$0.00$124.98M
2010-12-31$173.78M$25.61M$69.00M$115.99M$0.00$32.78M
2009-12-31$128.45M$36.56M$58.65M$112.52M(m)-$6.84M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Viatris Inc (VTRS)United States$20.008B-0.00
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28